Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open, within-patient comparative study of subcutaneous methotrexate 50 mg/ml vs 10 mg/ml in rheumatoid arthritis
2007-003591-19Phase 3Completed
- Sponsor
- medac GmbH
- Start
- Sep 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of methotrexate in rheumatoid arthritis (RA), sponsored by medac GmbH. Primary endpoint: Patient decision for future methotrexate therapy. Started Sep 2007; status: completed.
02
Drugs
methotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2007-003591-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003591-19.